DK0603301T3 - Farmaceutisk præparat indeholdende et urikosurikon og en excitatorisk-aminosyre-antagonist - Google Patents
Farmaceutisk præparat indeholdende et urikosurikon og en excitatorisk-aminosyre-antagonistInfo
- Publication number
- DK0603301T3 DK0603301T3 DK92919882T DK92919882T DK0603301T3 DK 0603301 T3 DK0603301 T3 DK 0603301T3 DK 92919882 T DK92919882 T DK 92919882T DK 92919882 T DK92919882 T DK 92919882T DK 0603301 T3 DK0603301 T3 DK 0603301T3
- Authority
- DK
- Denmark
- Prior art keywords
- amino acid
- excitatory amino
- acid antagonist
- uricosuricon
- pharmaceutical preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75640191A | 1991-09-09 | 1991-09-09 | |
PCT/US1992/007540 WO1993004688A1 (en) | 1991-09-09 | 1992-09-02 | Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0603301T3 true DK0603301T3 (da) | 1998-09-14 |
Family
ID=25043303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92919882T DK0603301T3 (da) | 1991-09-09 | 1992-09-02 | Farmaceutisk præparat indeholdende et urikosurikon og en excitatorisk-aminosyre-antagonist |
Country Status (16)
Country | Link |
---|---|
US (4) | US5407935A (no) |
EP (1) | EP0603301B1 (no) |
JP (1) | JP3218038B2 (no) |
AT (1) | ATE162075T1 (no) |
AU (1) | AU660717B2 (no) |
CA (1) | CA2115442C (no) |
DE (1) | DE69224069T2 (no) |
DK (1) | DK0603301T3 (no) |
ES (1) | ES2113957T3 (no) |
GR (1) | GR3026369T3 (no) |
MX (1) | MX9205127A (no) |
NO (1) | NO307645B1 (no) |
NZ (1) | NZ244243A (no) |
PT (1) | PT100850B (no) |
WO (1) | WO1993004688A1 (no) |
ZA (1) | ZA926837B (no) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE162075T1 (de) * | 1991-09-09 | 1998-01-15 | Warner Lambert Co | Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält |
US5318985A (en) * | 1991-12-20 | 1994-06-07 | Merrell Dow Pharmaceuticals Inc. | Potentiation of NMDA antagonists |
US5854217A (en) | 1992-09-28 | 1998-12-29 | Bearsden Bio, Inc. | Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
JPH07505908A (ja) * | 1992-09-28 | 1995-06-29 | マックセチーニ、マリア ルイザ | Nmda受容体のアロステリックモジュレーター |
WO1998003541A1 (en) | 1996-07-22 | 1998-01-29 | University Of Utah Research Foundation | Conantokins |
CA2261570A1 (en) | 1996-07-22 | 1998-01-29 | Cognetix, Inc. | Use of conantokins |
US6277825B1 (en) | 1996-07-22 | 2001-08-21 | University Of Utah Research Foundation | Use of conantokins for treating pain |
IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
IL139912A0 (en) * | 1998-05-26 | 2002-02-10 | Carlen Peter Louis | Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals |
US6399574B1 (en) | 2000-03-22 | 2002-06-04 | University Of Utah Research Foundation | Use of conantokins |
US7799794B2 (en) | 2000-06-28 | 2010-09-21 | Merck Sharp & Dohme Corp. | Treatment for cardiovascular disease |
US7276514B2 (en) * | 2002-05-15 | 2007-10-02 | Charitable Leadership Foundation - Medical Technology Acceleration Program | Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof |
US20080051428A1 (en) * | 2002-05-15 | 2008-02-28 | Davis Paul J | Pyrroloquinoline quinone drugs and methods of use thereof |
US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
EP1735057B1 (en) * | 2004-03-22 | 2015-02-25 | Apkarian Technologies LLC | Method and compositions for treatment of chronic neuropathic pain |
US8461223B2 (en) * | 2005-04-07 | 2013-06-11 | Aspen Aerogels, Inc. | Microporous polycyclopentadiene-based aerogels |
ITFI20050083A1 (it) * | 2005-04-29 | 2006-10-30 | Univ Firenze | Uso dell'acido chinurenico per la prevenzione e il trattamento dello shock |
CA2607953A1 (en) | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
US9181486B2 (en) | 2006-05-25 | 2015-11-10 | Aspen Aerogels, Inc. | Aerogel compositions with enhanced performance |
EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
ES2532210T3 (es) | 2010-09-10 | 2015-03-25 | Takeda Pharmaceuticals U.S.A., Inc. | Métodos para el tratamiento concomitante de teofilina y febuxostat |
US10806711B2 (en) | 2011-08-12 | 2020-10-20 | University Of Cincinnati | Method of treating acute decompensated heart failure with probenecid |
MX2015012547A (es) | 2013-03-13 | 2016-02-10 | Univ Cincinnati | Tratamiento de una disfuncion cardiaca diastolica con un agonista del receptor trpv2. |
US20170143681A1 (en) | 2015-11-02 | 2017-05-25 | Apkarian Technologies Llc | Methods and compositions for treating pain |
EP3427729A1 (en) * | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4812458A (en) * | 1986-09-16 | 1989-03-14 | A/S Ferrosan | 6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics |
DK146787A (da) * | 1987-03-23 | 1988-09-24 | Ferrosan | Heterocykliske forbindelser, deres fremstilling og anvendelse |
ES2122098T3 (es) * | 1991-02-28 | 1998-12-16 | Merrell Pharma Inc | Antagonistas del nmda. |
ATE162075T1 (de) * | 1991-09-09 | 1998-01-15 | Warner Lambert Co | Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält |
-
1992
- 1992-09-02 AT AT92919882T patent/ATE162075T1/de not_active IP Right Cessation
- 1992-09-02 AU AU25943/92A patent/AU660717B2/en not_active Ceased
- 1992-09-02 ES ES92919882T patent/ES2113957T3/es not_active Expired - Lifetime
- 1992-09-02 DK DK92919882T patent/DK0603301T3/da active
- 1992-09-02 EP EP92919882A patent/EP0603301B1/en not_active Expired - Lifetime
- 1992-09-02 JP JP50544593A patent/JP3218038B2/ja not_active Expired - Fee Related
- 1992-09-02 WO PCT/US1992/007540 patent/WO1993004688A1/en active IP Right Grant
- 1992-09-02 DE DE69224069T patent/DE69224069T2/de not_active Expired - Fee Related
- 1992-09-02 CA CA002115442A patent/CA2115442C/en not_active Expired - Fee Related
- 1992-09-07 NZ NZ244243A patent/NZ244243A/en unknown
- 1992-09-08 MX MX9205127A patent/MX9205127A/es not_active IP Right Cessation
- 1992-09-08 ZA ZA926837A patent/ZA926837B/xx unknown
- 1992-09-08 PT PT100850A patent/PT100850B/pt not_active IP Right Cessation
-
1993
- 1993-04-19 US US08/049,228 patent/US5407935A/en not_active Expired - Fee Related
-
1994
- 1994-03-08 NO NO940809A patent/NO307645B1/no not_active IP Right Cessation
-
1995
- 1995-10-05 US US08/539,398 patent/US5627168A/en not_active Expired - Fee Related
-
1996
- 1996-12-31 US US08/775,637 patent/US5767119A/en not_active Expired - Fee Related
-
1998
- 1998-03-13 GR GR980400554T patent/GR3026369T3/el unknown
- 1998-03-27 US US09/049,495 patent/US5942513A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3218038B2 (ja) | 2001-10-15 |
DE69224069D1 (de) | 1998-02-19 |
NO940809L (no) | 1994-03-08 |
NZ244243A (en) | 1995-07-26 |
ZA926837B (en) | 1994-03-08 |
NO940809D0 (no) | 1994-03-08 |
DE69224069T2 (de) | 1998-07-02 |
PT100850A (pt) | 1993-10-29 |
JPH06510544A (ja) | 1994-11-24 |
PT100850B (pt) | 1999-07-30 |
US5407935A (en) | 1995-04-18 |
US5767119A (en) | 1998-06-16 |
ES2113957T3 (es) | 1998-05-16 |
CA2115442A1 (en) | 1993-03-18 |
MX9205127A (es) | 1993-07-01 |
AU660717B2 (en) | 1995-07-06 |
US5942513A (en) | 1999-08-24 |
US5627168A (en) | 1997-05-06 |
EP0603301A1 (en) | 1994-06-29 |
ATE162075T1 (de) | 1998-01-15 |
AU2594392A (en) | 1993-04-05 |
GR3026369T3 (en) | 1998-06-30 |
NO307645B1 (no) | 2000-05-08 |
WO1993004688A1 (en) | 1993-03-18 |
CA2115442C (en) | 2003-09-23 |
EP0603301B1 (en) | 1998-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0603301T3 (da) | Farmaceutisk præparat indeholdende et urikosurikon og en excitatorisk-aminosyre-antagonist | |
PT705100E (pt) | Guanidinas substituidas terapeuticas | |
DK46789D0 (da) | 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf | |
UA26213C2 (uk) | Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові | |
DE69200685T2 (de) | Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten. | |
ES2182903T3 (es) | Derivados heterociclicos utiles en el tratamiento de enfermedades alergicas o reumaticas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
DE69009684D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen. | |
ATE171935T1 (de) | 2-amino-4-phenyl-4-oxo-buttersäure-derivate mit kynureninase und/oder kynurenin-3-hydroxylase inhibierender wirkung | |
EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
NO891703L (no) | Farmasoeytiske sammensetninger for behandling av psoriasis. | |
BR9812531A (pt) | Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica | |
NO993627L (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
NO880406L (no) | 5-(3-alkyl-5-tert-butyl-4-hydroksyfenyl)-2-amino-6h-1,3,4-tiadiaziner, fremgangsmaate til deres fremstilling og legemidler som inneholder dem og deres anvendelse. | |
ATE82850T1 (de) | Verwendung von 2-pyrimidinyl-1-piperazinderivaten. | |
FI914410A (fi) | Kalciumupptagande inhibitorer. | |
ITMI911930A1 (it) | Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico. | |
ITMI931174A0 (it) | Composizioni farmaceutiche per la cura della talassemia | |
EA199800575A1 (ru) | Производные пиперазина | |
DE59405654D1 (de) | T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen | |
DK8893D0 (da) | Medicament for treatment or prevention of disease |